4//SEC Filing
Taylor Ben R 4
Accession 0001601830-25-000083
CIK 0001601830other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:44 PM ET
Size
12.4 KB
Accession
0001601830-25-000083
Insider Transaction Report
Form 4
Taylor Ben R
Chief Financial Officer
Transactions
- Tax Payment
Class A Common Stock
2025-05-15$4.25/sh−11,908$50,609→ 830,191 total
Holdings
- 289,837
Stock Option (Right to Buy)
Exercise: $0.04Exp: 2030-11-26→ Class A Common Stock (0 underlying) - 81,154
Stock Option (Right to Buy)
Exercise: $0.14Exp: 2031-07-01→ Class A Common Stock (0 underlying) - 740,686
Stock Option (Right to Buy)
Exercise: $6.09Exp: 2034-12-18→ Class A Common Stock (0 underlying) - 70,037
Stock Option (Right to Buy)
Exercise: $7.25Exp: 2035-02-03→ Class A Common Stock (0 underlying) - 92,748
Stock Option (Right to Buy)
Exercise: $0.06Exp: 2031-04-02→ Class A Common Stock (0 underlying)
Footnotes (6)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
- [F2]The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
- [F3]1/48th of the shares subject to the award vests and become exercisable on January 2, 2025, and each month thereafter, subject to Mr. Taylor's continued service through each vesting date.
- [F4]Twenty-five percent of the shares subject to the award vest and become exercisable on July 1, 2022, and the remaining shares subject to the award vest and become exercisable in quarterly installments thereafter, subject to Mr. Taylor's continued service through each vesting date.
- [F5]Twenty-five percent of the shares subject to the award vest and become exercisable on April 3, 2022, and the remaining shares subject to the award vest and become exercisable in quarterly installments thereafter, subject to Mr. Taylor's continued service through each vesting date.
- [F6]Twenty-five percent of the shares subject to the award vest and become exercisable on November 17, 2021, and the remaining shares subject to the award vest and become exercisable in annual installments thereafter, subject to Mr. Taylor's continued service through each vesting date.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001712276
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:44 PM ET
- Size
- 12.4 KB